|
|
||||||||
Center for Oral Biology, University of Rochester, Rochester, NY 14642; william_bowen{at}urmc.rochester.edu
CONTROVERSY Caries is an unique dieto-bacterial disease and not simply an infection. The disease occurs on essentially an inanimate surface, and therefore the traditional methods of studying diseases may not apply. The following article brings into focus that, for decades, investigation of the pathogenesis of dental caries has been largely restricted to acid production. Now there is clear evidence that glucan production by bacteria from dietary substrate plays a critical role, and growing evidence that lack of alkali production by dental plaque is critical in the pathogenesis of this still-ubiquitous disease.
Olav Alvares, Editor
Introduction Nature of the Disease, Dental Caries Acid Production Acid Tolerance Enhancing the Effects of Fluoride Vaccines Early Diagnosis of Dental Caries Animal-based Research Translational Research Conclusion REFERENCES
| Abstract |
|---|
|
|
|---|
Key words. Dental caries, pathogenesis, glucans, fluoride
| Introduction |
|---|
|
|
|---|
National surveys over the years have revealed wide disparities in caries experience from one region of the United States to another. For example, when regional caries prevalence was first recorded, the highest prevalence was observed in the Northeastern part of the United States and the lowest in the Southwestern region. The differences observed in prevalence between the Northeastern United States and the Southwest region, if reported in a clinical trial, would be reason for excitement. Nevertheless, reasons for this disparity have received scant attention. Even within states, pockets of unusually low levels (Bowen, 1991) or high levels of caries have been reportedobservations which have rarely been pursued (Curzon, 1983).
| Nature of the Disease, Dental Caries |
|---|
|
|
|---|
The presence in pellicle of glucosyltransferases and fructosyltransferases in an active form, and the presence other unidentified bacterial products, has been known for more than a decade (Rølla et al., 1983a; Schilling and Bowen, 1988). Nevertheless, reports continue to appear referring to the mammalian constituents only. Clearly, an important facet of pellicle formation is being ignored, despite the fact that mutans streptococci and other oral micro-organisms adhere effectively to glucan surfaces formed when pellicle is exposed to sucrose. Furthermore, there appears to be a considerable degree of selectivity in the surfaces to which the various glucosyltransferases bind. For example, glucosyltransferase C binds avidly to saliva-coated hydroxyapatite in vitro (***Venkitaraman et al., 1995). An enzyme with similar properties is found in pellicle formed in vivo, although the exact source of the enzyme remains to be determined. In contrast, glucosyltransferase B binds preferentially to the surfaces of bacteria (Vacca-Smith and Bowen, 1998). The phenomenon of glucosyltransferases binding to oral bacteria was well-described by McCabe and Donkersloot (1977) and Rølla et al. (1983b). They observed that cell-free glucosyltransferase (Gtf) adheres equally as well to bacteria that produce Gtf as to those that do not make the enzyme. Thus, micro-organisms that bind the enzyme become de facto glucan producers. Clearly this phenomenon is highly relevant in the biology of dental plaque. Transmission electron microscopy with appropriate staining clearly shows that micro-organisms are enmeshed in a matrix of polysaccharide (Critchley et al., 1967). Furthermore, chemical analyses of dental plaque from humans and animals reveal that approximately 20% of the dry weight of plaque is composed of carbohydrate (Wood and Critchley, 1966; Hotz et al., 1972; Bowen et al., 1977). There is clear and unequivocal evidence that glucan production is essential for the expression of virulence by mutans streptococci. Deletion, from mutans streptococci, of the genes expressing enzymes responsible for glucan production leads to a dramatic reduction in the ability of the organism to induce dental caries in experimental animals (Yamashita et al., 1993). Despite the proven importance of glucan production in the pathogenesis of dental caries, virtually nothing has been published since 1972 on the formation and structure of glucan in dental plaque (Hotz et al., 1972). The research efforts expended on the formation and structure of glucan in vitro have also been sparse. Furthermore, efforts to inhibit glucosyltransferase as a means to prevent caries have been infrequent, despite the now-obvious importance of glucosyltransferases in the formation of dental plaque and in the pathogenesis of dental caries.
By aiming to prevent glucan production, therapeutic approaches to the prevention of caries would be precise: Unlike broad-spectrum antimicrobials, the oral flora would not necessarily be suppressed. The physical properties of dental plaque would certainly be altered by such an approach.
Dental cavitation results from a series of interactions which occur on a tooth surface. Understandably, most research on the physiology of cariogenic micro-organisms has been carried out with organisms in the planktonic state. However, most micro-organisms behave quite differently when they are attached to a surface. For example, Burne et al. (1997) have showed, using gene fusions to the gene promoter region of the glucosyltransferase B,C genes, that the polysaccharide synthesis pathway of S. mutans is expressed distinctively in biofilms. It was further shown that urease activity in biofilms of S. salivarius was enhanced by as much as 130-fold the level observed in fluid chemostat cultures cultivated under comparable conditions (Li et al., 2000).
Given that dental plaque is a biofilm, it is apparent that the biology of micro-organisms in dental plaque may differ in many ways compared with that observed in the planktonic state.
| Acid Production |
|---|
|
|
|---|
Perhaps one of the more fascinating physiological reactions which occur in dental plaque is the Stickland reaction. This reaction was first described by Stickland (1934) and was shown to occur in clostridia. A similar reaction was described by Curtis and Eastoe (1978) to occur in dental plaque. The reaction involves opening the proline ring and the acceptance of two protons from lactic acid, giving rise to delta amino valeric acid (Curtis and Kemp, 1983). Delta amino valeric acid has the fourth highest concentration of any amino acid in dental plaque. The peptostreptococci appear to be the major micro-organisms involved in this reaction in dental plaque (Curtis and Kemp, 1978). Clearly, this is a highly effective method of removing protons from the plaque, rendering the plaque less likely to dissolve enamel.
Many micro-organisms which lack acid tolerance mechanisms per se survive in dental plaque through the arginine deiminase system. This pathway has been well-described by Marquis and colleagues (1987) (Curran et al., 1995, 1998) and basically involves the generation of ammonia and carbon dioxide to prevent the pH of the immediate environment from declining to low values. This pathway is inducible at low pH values and is suppressed by the presence of glucose. An attractive approach might be to determine methods to avoid repression and to have the pathway active continuously. There is certainly no scarcity of arginine substrates in saliva (Casiano-Colon and Marquis, 1988).
Generation of alkali through the breakdown of urea has long been recognized as a major source of alkali in the mouth. Small amounts of urea (Kleinberg, 1967) are constantly found in saliva. In addition, many micro-organismse.g., S. salivarius and actinomycesproduce urease (Sissons et al., 1988). Results from studies conducted in animals show that there is an inverse relationship between dental plaque ureolytic capacity and cariogenicity (Clancy et al., 2000). Persons who have end-stage renal disease have reduced levels of caries experience, despite consuming elevated levels of sugar in their diet; they also exhibit elevated levels of urea in their saliva. The terminal pH of plaque exposed to sugar is also generally higher, even though the total amount of acid produced may be increased (Meyerowitz, 1993). Again, attempts to exploit this reaction clinically have been sparse and would appear to offer some promise for success.
| Acid Tolerance |
|---|
|
|
|---|
| Enhancing the Effects of Fluoride |
|---|
|
|
|---|
Available evidence shows clearly that the cariostatic effect of fluoride is heavily dependent on its ambient levels in the mouth (Larson and Mellberg, 1977; Mirth et al., 1982, 1983; Corpron et al., 1986). These observations suggest that low levels of fluoride constantly present in the mouth are critical for the expression of its maximum effect (Duckworth et al., 1987; Meyerowitz and Watson, 1998). Results from several clinical studies support this concept (Duckworth and Morgan, 1991); nevertheless, mechanisms of delivery of fluoride to the mouth have remained relatively unchanged for decades.
The antibacterial effects of fluoride have been largely ignored, despite clear evidence that fluoride, even in extremely low concentrations, can affect bacterial metabolism (Marquis, 1990). For example, fluoride in combination with aluminum is a potent inhibitor of ATPase, which plays a critical role in maintaining intracellular pH (Sutton et al., 1987; Sturr and Marquis, 1990). Fluoride also inhibits enolase at low pH values and, in addition, inhibits the uptake of sugars. Finally, it has been shown that fluoride affects the production of glucosyltransferase, which plays an essential role in the etiology and pathogenesis of dental caries (Bowen and Hewitt, 1974; Marquis, 1995). Fluoride behaves as a weak acid at low pH values: That is, in the protonated form, it can diffuse into cells as HF, where it can dissociate and affect the delta pH (Belli et al., 1995).
Recently, evidence has been gathered which shows that additional weak acids such as ketoprofen, benzoate, salicylate, and sorbate all enhance the weak acid effect of fluoride on bacterial metabolism (Ma et al., 1999; Bowen et al., 2000). Most of these agents are widely used and are regarded as safe. This area of research appears to offer exceptional promise as a means to enhance the clinical effect of fluoride.
| Vaccines |
|---|
|
|
|---|
Significant difference of opinions prevails over whether antibody for protection against caries should reside in the IgG or the IgA class of antibody studies (Bowen, 1996). It is argued that sIgA is the dominant immunoglobulin in the mouth, is resistant to proteases, and is the mucosal immunoglobulin. IgG, in contrast, is found in relatively low concentrations in saliva (but in high concentrations in the gingival fluid) and is susceptible to proteases (Brandtzaeg, 1983).
Universal agreement does not exist on the most appropriate immunogen to use as a vaccine. SpaA, antigen I/II (and additional names for the same immunogen), has been promoted over the years as the optimum antigen, based on the observation that the protein is involved in the adherence of mutans streptococci to saliva-coated hydroxyapatite. However, it has been shown that mutans streptococci which lack this protein through genetic manipulation are equally as cariogenic as the parent strain in rats (Yamashita et al., 1993). This observation certainly reduces the likelihood that this could serve as a protective immunogen.
Attention has also been focused on glucosyltransferase(s) as possible immunogens. Most mutans streptococci produce several different types of Gtf, each apparently with a distinct role in plaque physiology. Although antibody to one enzyme usually cross-reacts with other Gtfs, the level of inhibition may vary considerably.
Although the concept of vaccination against caries is attractive, several major problems continue to plague the field, including those listed above. Vaccination against caries is based on the idea that the same principles that apply to mucosal immunity are applicable to protection against caries. However, the disease dental caries occurs not on a mucosal surface but on a hard, non-shedding, largely non-reactive, surface: Protective antibody is required to react on a solid surface in a largely hostile environment with large variation in pH values, active proteases, and limited diffusion into and out of plaque. Furthermore, antibodies which react with epitopes on putative protective bacterial proteins in solution may not identify the same epitopes when the proteins adsorb to a surface and undergo conformational changes. Such changes are known to occur, for example, with glucosyltransferases adsorbed to saliva-coated hydroxyapatite (Vacca-Smith et al., 1996b).
It is assumed that even partial inhibition of glucosyltransferases by antibody may be beneficial. However, it is now clear that, in the presence of antibody which partially inhibits or simply reacts with the enzyme, a glucan of novel structure may be formed, thereby providing a distinctive structure to which micro-organisms may bind.
There has been an increasing interest in the possible use of topically applied antibodies as a means of controlling dental caries (Ma et al., 1995). This approach certainly has attractions in that immunogens do not have to be administered systemically. Nevertheless, although the approach is technically feasible, it shares many of the same problems mentioned above. In addition, depending on the method of administration, it may suffer from the same problem as any other mouthrinse or topical application, in that it does not remain in the mouth for a sufficient time to exert its therapeutic effect. Perhaps antibody could be used as a "homing agent" to deliver therapeutic substances to specific areas of the mouth.
| Early Diagnosis of Dental Caries |
|---|
|
|
|---|
The development of a simple, reliable method to diagnose caries, including, for example, non-clinical overt loss of tooth structure, could open the way for innovative approaches to the treatment of this ubiquitous disease. Preventive therapy could be initiated before cavitation, thereby reducing the cost of treatment and preserving tooth structure.
The current methods of conducting caries clinical trials are expensive, cumbersome, and time-consuming, and are certainly an impediment to the introduction of new therapeutic agents and the refinement of existing products. Enhanced methods for detecting caries activity, including detection of pre-clinical enamel loss, would certainly accelerate the conduct of trials and would probably give rise to more meaningful clinical results. Trials as currently conducted measure caries lesions which may have been initiated before the study commenced. In general, they do not inform us of the effect, if any, that the agent has on the disease; furthermore, it is widely assumed that if an agent slows the development of lesions for 1-2 years, it will be clinically effective for the subject's life.
| Animal-based Research |
|---|
|
|
|---|
Nevertheless, the need for high-quality animal models to study dental caries is likely to increase. With the development of new and more sophisticated animal models such as transgenics, it will be possible to define, very precisely, the role of various salivary constituents in preventing or enhancing susceptibility to dental caries. Furthermore, it is conceivable that truly caries-resistant enamel and even replacement teeth could be developed.
The need for more conventional animal models will continue, despite efforts to replace them by in situ demineralization and remineralization models. The in situ models may be appropriate for the study or development of agents where the mode of action is similar to that of fluoride. Such "tunnel vision" on the development of new products is not in the best interests of the public at large, and has the potential to stifle the development of new anti-caries agents.
| Translational Research |
|---|
|
|
|---|
The effectiveness of the sustained release of fluoride in the mouth has been shown in animals and in humans. Nevertheless, introduction of this procedure as a means to prevent cavitation has been tardy at best (Mirth et al., 1982; Corpron et al., 1986; Meyerowitz and Watson, 1998). This approach to the therapeutic use of fluoride offers numerous advantages in specialized patients compared with conventional approaches to fluoride therapy. For example, reduced amounts of fluoride are needed to achieve a given result, and compliance by the patient is complete.
| Conclusion |
|---|
|
|
|---|
| REFERENCES |
|---|
|
|
|---|
Bender GR, Marquis R (1987). Membrane ATPases and acid tolerance of Actinomyces viscosus and Lactobacillus casei. Appl Environ Microbiol53:21242128.
Bender GR, Sutton SV, Marquis RE (1986). Acid tolerance, proton permeabilities, and membrane ATPases of oral streptococci. Infect Immun53:331338.
Bowden G (1993). Promoting the disposition of acid in dental plaque. In: Cariology for the nineties. Bowen WH, Tabak LA, editors. Rochester, NY: University of Rochester Press, pp. 421-439.
Bowen WH (1976). Relevance of caries vaccine investigations in rodents, primates and humans: critical assessment. In: Immunologic aspects of dental caries. Bowen WH, Genco RJ. O'Brien TC, editors. Spec Suppl, Immunol Abstr. Washington, DC: Information Retrieval Inc., pp. 11-20.
Bowen WH (1991). Dental caries: is it an extinct disease? J Am Dent Assoc122:4952. [Abstract]
Bowen WH (1996). Vaccine against dental cariesa personal view. J Dent Res75:15301533.
Bowen WH, Hewitt MJ (1974). Effect of fluoride on extracellular polysaccharide production by Streptococcus mutans. J Dent Res53:331338.
Bowen WH, Velez H, Aguila M, Velasquez H, Sierra LI, Gillespie G (1977). The microbiology and biochemistry of plaque, saliva, and drinking water from two communities with contrasting levels of caries in Colombia, S.A. J Dent Res56(Spec Iss):C32C39.
Bowen WH, Pearson SK, Jerussi T (2000). Influence of (S)-ketoprofen and fluoride on caries in rats. Oral Diseases6:1214. [Medline]
Brandtzaeg P (1983). Role of antibodies in saliva: facts and extrapolations. In: Cariology today. Guggenheim B, editor. International Congress Zürich, 1984. Basel: Karger, pp. 89-97.
Burne R, Chen YM, Penders JE (1997). Analysis of gene expression in Streptococcus mutans in biofilms in vitro. Adv Dent Res11:100109. [Abstract]
Casiano-Colon A, Marquis RE (1988). Role of the arginine deiminase system in protecting oral bacteria and an enzymatic basis for acid tolerance. Appl Environ Microbiol54:13181324.
Clancy K, Pearson S, Bowen WH, Burne RA (2000). Characterization of recombinant, ureolytic Streptococcus mutans demonstrates an inverse relationship between dental plaque ureolytic capacity and cariogenicity. Infect Immun68:26212629.
Corpron RE, Clark JW, Tsai A, More FG, Merrill DF, Kowalski CJ, et al. (1986). Intraoral effects of a fluoride releasing device on acid-softened enamel. J Am Dent Assoc113:383388. [Abstract]
Critchley P, Wood JM, Saxton CA, Leach SA (1967). The polymerization of dietary sugars by dental plaque. Caries Res1:112129. [Medline]
Curran TM, Lieou J, Marquis RE (1995). Arginine deiminase system and acid adaptation of oral streptococci. Appl & Environ Microbiol61:44944496. [Abstract]
Curran TM, Ma Y, Rutherford GC, Marquis RE (1998). Turning on and turning off the arginine deiminase system in oral streptococci. Can J Microbiol44:10781085. [Medline]
Curtis M, Eastoe I (1978). Comparison of free amino acid pools in dental plaque fluid from monkeys (Macaca fascicularis) fed on high and low sugar diets. Arch Oral Biol23:989992. [Medline]
Curtis MA, Kemp CW (1983). Nitrogen metabolism in dental plaque. In: Cariology today. Guggenheim B, editor. International Congress Zürich, 1984. Basel: Karger, pp. 212-222.
Curzon ME (1983). Trace elements and dental disease. Curzon ME, Cutress TW, editors. Bristol: John Wright, PSG Inc., pp. 11-30.
DePaola PF (1993). Caries in our aging population: what are we learning? In: Cariology for the nineties. Bowen WH, Tabak LA, editors. Rochester, NY: University of Rochester Press, pp. 25-35.
Duckworth R, Morgan S (1991). Oral fluoride retention after use of fluoride dentifrices. Caries Res25:123129.
Duckworth R, Morgan SN, Murray A (1987). Fluoride in saliva and plaque following use of fluoride-containing mouthwashes. J Dent Res66:17301734.
Edelstein BL, Douglass CW (1995). Dispelling the myth that 50 percent of U.S. schoolchildren have never had a cavity. Public Health Report110:522530. [Medline]
Eisenberg AD, Bender GR, Marquis RE (1980). Reduction in the aciduric properties of the oral bacterium Streptococcus mutans GS-5 by fluoride. Arch Oral Biol25:133135. [Medline]
Eggertsson H, Analoui M, van der Veen M, Gonzalez-Cabezas C, Eckert G, Slokey G (1999). Detection of early interproximal caries in vitro using laser fluorescence, dye-enhanced laser fluorescence and direct visual examination. Caries Res33:227233. [Medline]
Fischman SL (1992). Hare's teeth to fluorides, historical aspects of dentifrice use. In: Clinical and biological aspects of dentifrices. Embery G, Rølla G, editors. New York: Oxford University Press, pp. 1-7.
Geddes DAM (1975). Acids produced by human dental plaque metabolism in situ. Caries Res9:98109. [Medline]
Glass RL (1982). The first international conference on the declining prevalence of dental caries. J Dent Res61(Spec Iss):1304.
Hay DI, Moreno EC (1993). Hydroxyapatite-interactive proteins. In: Cariology for the nineties. Bowen WH, Tabak LA, editors. Rochester, NY: University of Rochester Press, pp. 71-84.
Hotz P, Guggenheim B, Schmid R (1972). Carbohydrates in pooled dental plaque. Caries Res6:103121. [Medline]
Klein H (1946). The family and dental disease: dental disease (DMF) experience in parents and offspring. J Am Dent Assoc33:735743.
Kleinberg I (1967). Effect of urea concentration on human plaque pH levels in situ. Arch Oral Biol12:14751484. [Medline]
Larson R, Mellberg J (1977). Experiments on local and systemic action of fluoride in caries inhibition in the rat. Arch Oral Biol22:437439. [Medline]
Leverett DH, Proskin HM, Featherstone JD, Adair SM, Eisenberg AD, Mundorff-Shrestha SA, et al. (1993). Caries risk assessment in a longitudinal discrimination study. J Dent Res72:538543.
Li G-H, Chen Y-Y, Burne R (2000). Regulation of urease gene expression by Streptococcus salivarius growing in biofilms. Environmental Micro2:169177.
Lussi A, Imwinkelried S, Pitts N, Longbottom C, Reich E (1999). Performance and reproducibility of a laser fluorescence system for detection of occlusal caries in vitro. Caries Res33:261266. [Medline]
Ma JK, Hiatt A, Hein M, Vine ND, Wang F, Stabila P (1995). Generation and assembly of secretory antibodies in plants. Science268:716719.
Ma Y, Rutherford GC, Curran TM, Reidmiller JS, Marquis RE (1999). Membrane locus and pH sensitivity of paraben inhibition of alkali production by oral streptococci. Oral Microbiol Immunol14:244249. [Medline]
Mandel I (1993). Dental caries: another extinct disease? In: Cariology for the nineties. Bowen WH, Tabak LA, editors. Rochester, NY: University of Rochester Press, pp. 1-10.
Marquis RE (1990). Diminished acid tolerance of plaque bacteria caused by fluoride. J Dent Res69:672675.
Marquis RE (1995). Antimicrobial actions of fluoride for oral bacteria. Can J Microbiol41:955964. [Medline]
Marquis RE, Bender GR, Murray DR, Wong A (1987). Arginine deiminase system and bacterial adaptation to acid environments. Appl Environ Microbiol53:198200.
McCabe RM, Donkersloot JA (1977). Adherence of Veillonella species mediated by extracellular glucosyltransferase from Streptococcus salivarius. Infect Immun18:726734.
Meyerowitz C (1993). Caries in renal dialysis patients. In: Cariology for the nineties. Bowen WH, Tabak LA, editors. Rochester, NY: University of Rochester Press, pp. 249-260.
Meyerowitz C, Watson GE (1998). The efficacy of an intraoral fluoride-releasing system in irradiated head and neck cancer patients: a preliminary study. J Am Dent Assoc129:12521259.
Mirth DB, Shern RJ, Emilson CG, Adderly DD, Li SH, Gomez IM, et al. (1982). Clinical evaluation of an intraoral device for the controlled release of fluoride. J Am Dent Assoc105:791797. [Abstract]
Mirth DM, Adderley DD, Amsbaugh SM, Monell-Torrens E, Li SH, Bowen WH (1983). Inhibition of experimental caries using an intraoral fluoride-releasing device. J Am Dent Assoc107:5559. [Abstract]
National Institutes of Health (1987). Oral health of United States adults. The national survey of oral health in U.S. employed adults and seniors: 1985-1986. National findings. NIH publication no. 87-2868. Washington, DC: US Government Printing Office.
National Institutes of Health (1989). Oral health of United States children. The national survey of dental caries in U.S. school children: 1986-1987. National and regional findings. NIH publication no. 89-2247. Washington, DC: US Government Printing Office.
Quivey RG, Kuhnert WL, Hahn K (2000). Adaptation of oral streptococci to low pH. Adv Micro Physiol42:239274. [Medline]
Rølla G, Ciardi J, Bowen WH (1983a). Identification of IgA, IgG, lysozyme, albumin, amylase and glucosyltransferase in the protein layer adsorbed to hydroxyapatite from whole saliva. Scand J Dent Res91:186190. [Medline]
Rølla G, Ciardi J, Eggen K, Bowen WH, Afseth J (1983b). Free glucosyl- and fructosyltransferase in human saliva and adsorption of these enzymes to teeth in vivo. Proceedings: Glucosyltransferases, glucans, sucrose and dental caries. Doyle RJ, Ciardi JE, editors. Washington, DC: Chemical Senses (Sp Suppl), pp. 21-29.
Russell RRB, Colman C (1981). Immunization of monkeys (Macaca fascicularis) with purified Streptococcus mutans glucosyltransferase. Arch Oral Biol26:2328. [Medline]
Schilling K, Bowen WH (1988). The activity of glucosyltransferase adsorbed onto saliva-coated hydroxyapatite. J Dent Res67:28.
Sissons CH, Hancock EM, Perinpanayagam H, Cutress T (1988). The source and variation in ureolysis in artificial plaques, cultures from human salivary bacteria. Arch Oral Biol33:721734. [Medline]
Stephan RM (1944). Intra-oral hydrogen-ion concentrations associated with dental caries activity. J Dent Res23:257266.
Stephen K (1993). Caries in young populationsworldwide. In: Cariology for the nineties. Bowen WH, Tabak LA, editors. Rochester, NY: University of Rochester Press, pp. 71-84.
Stickland LH (1934). Studies in the metabolism of the strict anaerobes (Genus Clostridium. I.). The chemical reactions by which Cl. sporogenes obtains its energy. Biochem J28:17461759.
Sturr MG, Marquis RE (1990). Inhibition of proton-translocating ATPases of Streptococcus mutans and Lactobacillus casei by fluoride and aluminum. Arch Micro155:2227.
Sutton SV, Bender GR, Marquis RE (1987). Fluoride inhibition of proton-translocating ATPases of oral bacteria. Infect Immun55:25972603.
Tanzer J, editor (1981). Animal models in cariology. Spec Suppl, Microbiol Abstr, pp. XXIXXII.
Taubman MA, Smith DJ (1993). Vaccination: a cariostatic option? In: Cariology for the nineties. Bowen WH, Tabak LA, editors. Rochester, NY: University of Rochester Press, pp. 441-457.
Vacca-Smith A, Bowen WH (1998). Binding properties of streptococcal glucosyltransferases for hydroxyapatite, saliva-coated hydroxyapatite, and bacterial surfaces. Arch Oral Biol43:103110. [Medline]
Vacca-Smith A, Venkitaraman A, Quivey R, Bowen WH (1996a). Interactions of streptococcal glucosyltransferases with
amylase and starch on the surface of saliva-coated hydroxyapatite. Arch Oral Biol3:291298.
Vacca-Smith A, Venkitaraman AR, Schilling KM, Bowen WH (1996b). Characterization of glucosyltransferase of human saliva adsorbed onto hydroxyapatite surface. Caries Res30:354360. [Medline]
Venkitaraman A, Vacca-Smith A, Kopec L, Bowen WH (1995). Characterization of glucosyltransferase B, gtfC and gtfD in solutions and on the surface of hydroxyapatite. J Dent Res74:16951701.
Wood JM, Critchley P (1966). The extracellular polysaccharide produced from sucrose by a cariogenic streptococcus. Arch Oral Biol11:10391042. [Medline]
Yamashita Y, Bowen WH, Burne RA, Kuramitsu HK (1993). Role of Streptococcus mutans glucosyltransferase genes in caries induction in the specific-pathogen-free rat model. Infect Immun61:38113817.
This article has been cited by other articles:
![]() |
H. Koo Strategies to Enhance the Biological Effects of Fluoride on Dental Biofilms Adv. Dent. Res., July 1, 2008; 20(1): 17 - 21. [Full Text] [PDF] |
||||
![]() |
A.F. P. Leme, H. Koo, C.M. Bellato, G. Bedi, and J.A. Cury The role of sucrose in cariogenic dental biofilm formation--new insight. J. Dent. Res., October 1, 2006; 85(10): 878 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Koo, J. Seils, J. Abranches, R. A. Burne, W. H. Bowen, and R. G. Quivey Jr. Influence of Apigenin on gtf Gene Expression in Streptococcus mutans UA159 Antimicrob. Agents Chemother., February 1, 2006; 50(2): 542 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Koo, B. Schobel, K. Scott-Anne, G. Watson, W.H. Bowen, J.A. Cury, P.L. Rosalen, and Y.K. Park Apigenin and tt-Farnesol with Fluoride Effects on S. mutans Biofilms and Dental Caries J. Dent. Res., November 1, 2005; 84(11): 1016 - 1020. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| IADR Journals | Advances in Dental Research ® | Journal of Dental Research ® | Critical Reviews (1990-2004) |